Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial
Resolution happens faster
While MT2 also has the potential to activate MC1R and stimulate melanogenesis, the peptide has a broader affinity towards other melanocortin receptors
You need this antioxidant for memory, attention, and overall brain health because it reduces oxidative stress, especially in brain cells
Patients are randomized to pemvidutide 1.2 or 1.8 mg weekly, or placebo for 24 weeks, with primary endpoints of MASH resolution without fibrosis progression and fibrosis amelioration without MASH deterioration
Morland C, Nordengen K (2022) N-Acetyl-Aspartyl-Glutamate in brain health and disease